Claus-Christoph Steffens
- Oncology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Hepatology top 2%
- Pathology and Forensic Medicine top 10%
- Cancer Research
- Co-authors
- Dirk ArnoldChristophe BorgRoger von MoosJavier SastreJosé María ViéitezVicente Alonso-OrduñaIrmarie Reyes‐RiveraStefan Kubicka
- Topics
- Colorectal Cancer Treatments and Studies (12 papers)Cancer Treatment and Pharmacology (9 papers)Gastric Cancer Management and Outcomes (4 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Claus-Christoph Steffens
17 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 58
- Oncology 972
- Pulmonary and Respiratory Medicine 481
- Hepatology 310
- Pathology and Forensic Medicine 164
- Cancer Research 149
Countries citing papers authored by Claus-Christoph Steffens
This map shows the geographic impact of Claus-Christoph Steffens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claus-Christoph Steffens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claus-Christoph Steffens more than expected).
Fields of papers citing papers by Claus-Christoph Steffens
This network shows the impact of papers produced by Claus-Christoph Steffens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claus-Christoph Steffens. The network helps show where Claus-Christoph Steffens may publish in the future.
Co-authorship network of co-authors of Claus-Christoph Steffens
This figure shows the co-authorship network connecting the top 25 collaborators of Claus-Christoph Steffens. A scholar is included among the top collaborators of Claus-Christoph Steffens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claus-Christoph Steffens. Claus-Christoph Steffens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 4 | |
| 3 | 18 | |
| 4 | 0 | |
| 5 | 176 | |
| 6 | 3 | |
| 7 | 9 | |
| 8 | 7 | |
| 9 | 21 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 1 | |
| 13 | Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trialbreakdown → | 829 |
| 14 | 4 | |
| 15 | 4 | |
| 16 | 3 | |
| 17 | Scanning electron microscopic studies on the vascular system of xenotransplanted tumours. | 1 |
| 18 | [Metatropic dwarfism. Different reversal of spine deformity in monozygotic twins (author's transl)]. | 1 |
About Claus-Christoph Steffens
Claus-Christoph Steffens is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Cancer Treatment and Pharmacology (9 papers) and Gastric Cancer Management and Outcomes (4 papers). The work is most often cited by research in Hepatology (310 citations), Oncology (972 citations) and Pulmonary and Respiratory Medicine (481 citations). Claus-Christoph Steffens has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Dirk Arnold, Christophe Borg, Roger von Moos, Javier Sastre, José María Viéitez, Vicente Alonso-Orduña, Irmarie Reyes‐Rivera, Stefan Kubicka, C. Schlichting and Pia Österlund. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.